TNFSF11 and Langerhans cell histiocytosis: In support of this hypothesis, RANKL was found to be abundantly expressed in cells within inflammatory infiltrates of various osseous and non-osseous LCH lesions, which in turn may activate OC-like multinucleated giant cells [23], pointing out RANKL inhibition as a rational therapeutic approach for the management of the disease.